Global Diabetes Drugs market | Inkwood Research
                     GLOBAL DIABETES DRUGS 
FOREMCAASRT 2K0E1T9-2027
TREY 1
research
Insert or Drag & Drop your photo MARKET 
GLOBAL DIABETES 
DRUGS MARKET OVERVIEW
• The important driver for the growth in this 
FORECAST 2019-2027 market is the increase in the prevalence of diabetes which is because of the increasing 
obesity among people caused by unhealthy 
diets and sedentary lifestyles.
•  The diabetes drugs market segments 
include diabetes type and product class.
• Diabetes drugs manufacturers offer products 
for use by both the types (type 1 and type 2) 
of diabetic patients.
• Growing elderly population is also 
influencing the market growth in a big way 
as the life expectancy rate is rising and the 
birth rate is declining at the same time.
TREY 
2
research
KEY 
• The growth in the global diabetes drugs 
FmaIrNket iDs maIinNly dGriven by increased diabetic population anSd obesity rates in 
recent years. 
• The North American market holds the 
largest share of the global market.
• The global diabetes drugs market is 
expected to grow at a CAGR of 6.50% 
during the forecast period of 2019-2027.
INTRODUCTI
ON
Global Diabetes Drugs market by 
Diabetes type, by Product class, by 
Non-Insulin & by geography.
TREY 
3
research
TREY 
 4
research
Infograp
hic
REQUEST FREE SAMPLE
To know more about the latest trends  and innovation 
in the “Global Diabetes Drugs market”
Request free 
sample
TREY  5
research
NORTH AMERICA DIABETES DRUGS MARKET
• The expected CAGR of the North 
American diabetes drugs market over 
the forecast period of 2019-2027 is 
4.98%.
• The region has the world’s most 
established market for diabetes drugs 
and holds more than half of the total 
market share. 
• The US market holds the maximum 
share in the sale and distribution of 
diabetes drugs.
Request free 
sample TREY  6
research
EUROPE DIABETES DRUGS MARKET
• The CAGR for the European market of 
diabetes drugs is expected to be 5.09% 
for the forecast period of 2019-2027. 
• The increase in life expectancy 
contributes to the increase in the 
number of diseases prevailing in the 
region, especially diabetes. Implications 
caused by diabetes such as CVDs, 
kidney failure, foot ulcers and damage 
to the eyes have made people in Europe 
more conscious about diabetes 
management.
Request free 
sample TREY  7
research
ASIA PACIFIC DIABETES DRUGS MARKET
• The CAGR for the Asia Pacific diabetes 
drugs market is expected to be 10.82% 
for the forecast period of 2019-2027.
• Economic development and rise in 
healthcare spending are expected to 
increase the demand for diabetes drugs 
further.
• Despite a large number of people with 
diabetes in the region, awareness is still 
low, and therefore the situation needs to 
be addressed.
Request free 
sample TREY  8
research
COMPETITIVE 
INSIGHTS
Leading brands in the global market of 
diabetes drugs are Eli Lilly And Company, 
AstraZeneca Plc., B.Braun Melsungen Ag, 
Novo Nordisk A/S, Sanofi, Diavacs Inc., 
Xoma Corp., Albireo Pharma Inc., 
Macrogenics Inc., Astellas Pharma, 
Glaxosmithkline, Merck, Pfizer and Xeris 
Pharmaceuticals.
TREY  9
research
ABOUT US
Inkwood Research specializes in syndicated research reports, 
customized research reports and consulting services. We offer market 
intelligence studies across a range of industries including Technology, 
Chemicals, Materials, Healthcare and Energy. With 20 years of 
research experience, we ensure you efficient deliverables with global 
and country industry knowledge and research expertise. Our analysis 
covers North & South America, Europe, CEE, CIS, Middle East, Africa 
and Asia.
TREY  
research 1
0
CONTACT 
US
+1 857-302-4704
[email protected]
om
https://www.inkwoodresearch.c
om/
TREY 1
research 1
THANK YOU
Follow us on: 
TREY 
112
research 2